Drug intelligence / Profile preview

UIC202004

Development stage: Unknown
Lead developer: Korea United Pharm
Modality: Small Molecules
Administration: Oral

Overview

UIC202004 is a small molecule drug developed by Korea United Pharm for the treatment of digestive system disorders, including gastroesophageal reflux disease (GERD). It has been studied in clinical trials to compare its pharmacokinetics, pharmacodynamics, and safety profile with another compound, UI058. The drug is currently in early-stage clinical development and has not yet received regulatory approval. Its precise mechanism of action and molecular target have not been publicly disclosed.

Beyond the preview

Go deeper on UIC202004.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on UIC202004.

Explore the full profile